Gainers
- Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
- Altamira Therapeutics Ltd. (NASDAQ: CYTO) climbed 58.6% to close at $0.5197 on Friday after the company announced divestiture of its inner ear development assets.
- Missfresh Limited (NASDAQ: MF) gained 57.5% to close at $2.52.
- Enservco Corporation (NYSE: ENSV) climbed 37.4% to close at $2.02.
- Kaleyra, Inc. (NYSE: KLR) gained 24.9% to close at $0.8616.
- Veris Residential, Inc. (NYSE: VRE) surged 23.3% to close at $15.31 after Kushner Companies made an offer to acquire the company for $16 per share.
- Matinas BioPharma Holdings, Inc. (NYSE: MTNB) rose 22.2% to settle at $0.8538. Matinas BioPharma announced interim data from the Phase 2 EnACT trial of MAT2203 for the treatment of cryptococcal meningitis, exceeding primary endpoint threshold.
- Candel Therapeutics, Inc. (NASDAQ: CADL) gained 21.6% to close at $1.80.
- Energy Focus, Inc (NASDAQ: EFOI) shares climbed 21.5% to close at $0.4900. Energy Focus, last month, named Lesley Matt as CEO.
- Leju Holdings Limited (NYSE: LEJU) gained 21.1% to settle at $1.61.
- Rail Vision Ltd. (NASDAQ: RVSN) gained 20.5% to close at $0.5898.
- Rockley Photonics Holdings Limited (NYSE: RKLY) surged 20.1% to settle at $0.6262.
- The Boston Beer Company, Inc. (NYSE: SAM) jumped 19.7% to close at $402.28 after the company reported better-than-expected Q3 adjusted EPS and sales results.
- MacroGenics, Inc. (NASDAQ: MGNX) rose 19.4% to close at $4.80.
- TuanChe Limited (NASDAQ: TC) climbed 19.1% to settle at $7.87.
- Zentek Ltd. (NASDAQ: ZTEK) gained 18.9% to close at $1.57.
- Yunji Inc. (NASDAQ: YJ) rose 18.6% to close at $1.02.
- Snow Lake Resources Ltd. (NASDAQ: LITM) climbed 18.5% to close at $2.43.
- Biohaven Ltd. (NYSE: BHVN) gained 17.7% to close at $14.08. Biohaven reported pricing of public offering of 25 million common shares at a price of $10.50 per share.
- Amprius Technologies, Inc. (NASDAQ: AMPX) climbed 17.6% to close at $11.11. Amprius Technologies was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
- Healthcare Triangle, Inc. (NASDAQ: HCTI) gained 17.2% to close at $0.3875.
- AppTech Payments Corp. (NASDAQ: APCX) gained 16.4% to settle at $0.8849.
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) climbed 16.3% to close at $7.77.
- Biotricity, Inc. (NASDAQ: BTCY) rose 15.7% to close at $1.10.
- uCloudlink Group Inc. (NASDAQ: UCL) rose 15.5% to close at $0.69.
- Intelligent Living Application Group Inc. (NASDAQ: ILAG) rose 14.9% to close at $2.70.
- Microvast Holdings, Inc. (NASDAQ: MVST) surged 13.1% to close at $2.50.
- Novavax, Inc. (NASDAQ: NVAX) gained 12.6% to close at $19.34 in sympathy with Pfizer (NYSE:PFE), which is reportedly thinking about increasing the price for COVID-19 boosters.
- Atara Biotherapeutics, Inc. (NASDAQ: ATRA) jumped 12.5% to close at $4.23
- Piedmont Lithium Inc. (NASDAQ: PLL) rose 12.1% to close at $60.02.
- 1st Source Corporation (NASDAQ: SRCE) gained 12.1% to close at $55.89.
- BioNTech SE (NASDAQ: BNTX) climbed 11.2% to close at $131.64 following reports suggesting vaccine makers could possibly raise the prices of COVID-19 shots.
- Schlumberger (NYSE:SLB) Limited (NYSE: SLB) gained 10.3% to close at $50.41 following upbeat quarterly earnings.
- Calliditas Therapeutics AB (NASDAQ: CALT) gained 10.3% to settle at $12.68 after dipping 15% on Thursday.
- Super League Gaming, Inc. (NASDAQ: SLGG) gained 10.2% to close at $0.6835.
- Huntington Bancshares Incorporated (NASDAQ: NASDAQ:HBAN) gained 9.5% to close at $14.45 after the company reported better-than-expected Q3 EPS results.
- Pennsylvania Real Estate Investment Trust (NYSE: PEI) rose 9.4% to close at $2.90.
- Hawaiian Holdings, Inc. (NASDAQ: HA) shares gained 8.9% to close at $15.33. Hawaiian Airlines announced an agreement with Amazon (NASDAQ:AMZN) to operate freighter aircraft.
- Moderna (NASDAQ:MRNA), Inc. (NASDAQ: MRNA) surged 8.4% to close at $128.32 after SVB Leerink upgraded the stock from Underperform to Market Perform and raised the price target from $74 to $101.
- Statera Biopharma, Inc. (NASDAQ: STAB) gained 8.2% to close at $0.1658. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
- FedNat Holding Company (NASDAQ: FNHC) gained 6.6% to close at $0.5960 after dipping over 8% on Thursday.
Losers
- Immunic, Inc. (NASDAQ: IMUX) shares tumbled 77.4% to close at $2.08 on Friday after the company reported the pre-planned Phase 1b interim analysis of IMU-935 in psoriasis patients was confounded by a high placebo rate. Two active arms did not separate from the placebo.
- NextPlay Technologies, Inc. (NASDAQ: NXTP) declined 33.2% to close at $0.2763. NextPlay Technologies recently announced its NextFintech division received commitment for a $15 million strategic investment.
- Kalera Public Limited Company (NASDAQ: KAL) dropped 32.5% to close at $0.2768.
- Tenet Healthcare Corporation (NYSE: NYSE:THC) dipped 31% to close at $37.50 after the company reported worse-than-expected Q3 sales results and issued Q4 and FY22 adjusted EPS and sales guidance below estimates.
- Snap Inc . (NYSE: NYSE:SNAP) fell 28.1% to close at $7.76 following Q3 results. The company said it will not provide Q4 expectations due to uncertainties in the operating environment but believes it is likely that year-over-year revenue growth will decelerate as it moves through Q4. The company also said total time spend watching content in the US decreased 5% year over year.
- authID Inc. (NASDAQ: AUID) dropped 27.5% to close at $1.00.
- Sientra, Inc. (NASDAQ: SIEN) fell 26.4% to close at $0.29. Sientra recently announced a proposed public offering.
- SVB Financial Group (NASDAQ: SIVB) dropped 24% to $230.03 after the company reported Q3 earnings results. Following earnings, multiple firms downgraded the stock.
- Starry Group Holdings, Inc. (NYSE: STRY) fell 22.7% to close at $0.8501. Starry announced a 50% workforce reduction and withdrew FY22 guidance.
- Kala Pharmaceuticals, Inc. (NASDAQ: KALA) fell 20% to close at $8.00. Kala Pharmaceuticals announced a 1-for-50 reverse stock split.
- SenesTech, Inc. (NASDAQ: SNES) shares fell 19.5% to close at $0.2253 after declining around 18% on Thursday.
- COMSovereign Holding Corp. (NASDAQ: COMS) fell 19.5% to close at $0.0808.
- Quanergy Systems, Inc. (NYSE: QNGY) fell 19.1% to close at $1.53.
- 9 Meters Biopharma, Inc. (NASDAQ: NMTR) declined 19% to close at $2.18.
- Eterna Therapeutics Inc. (NASDAQ: ERNA) dropped 18.5% to settle at $3.65.
- Alfi, Inc. (NASDAQ: ALF) fell 16.1% to close at $0.2432.
- Rubicon Technologies, Inc. (NYSE: RBT) fell 15.4% to close at $1.92.
- Katapult Holdings, Inc. (NASDAQ: KPLT) dropped 15.1% to close at $0.9335.
- Bit Origin Ltd (NASDAQ: BTOG) fell 14.9% to close at $0.2722.
- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) fell 14.8% to close at $3.35.
- Community Health Systems, Inc. (NYSE: CYH) dipped 13.9% to close at $2.05.
- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) dropped 12.8% to settle at $7.10. Aurinia Pharmaceuticals announced departure of Executive Vice President, Research and Chief Medical Officer.
- NLS Pharmaceutics AG (NASDAQ: NLSP) dipped 12.1% to settle at $0.4792.
- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) dropped 10.6% to close at $4.58.
- Zovio Inc (NASDAQ: ZVO) declined 9.5% to close at $0.1766 after declining 7% on Thursday.
- First Financial Bankshares, Inc. (NASDAQ: FFIN) dipped 9.1% to close at $39.10. First Finl Bankshares posted Q3 EPS of $0.41.
- Robert Half International Inc. (NYSE: NYSE:RHI) shares fell 8.6% to close at $73.01 after reporting downbeat Q3 earnings.
- Surgery Partners, Inc. (NYSE: SGRY) dropped 7.4% to close at $24.33.
- Pinterest (NYSE:PINS), Inc. (NYSE: PINS) fell 6.4% to close at $21.50 in sympathy with Snap, which gave an uncertain fourth-quarter outlook.
- HCA (NYSE:HCA) Healthcare, Inc. (NYSE: HCA) fell 5.7% to close at $196.66 after the company reported worse-than-expected Q3 sales results.
- Twitter, Inc. (NYSE: TWTR) shares fell 4.9% to close at $49.89. The U.S. is reportedly discussing the possibility of subjecting Elon Musk’s companies to national security reviews. Musk has also been locked in a battle over buying Twitter. The U.S. government is reportedly unhappy with the billionaire mobilizing financing from foreign high-net-worth individuals to consummate the deal.